Dr. Rémi Longuespée obtained a PhD in Life Sciences at the University of Lille (France) and a PhD of Biochemistry at the University of Sherbrooke (Canada) in 2012. He dedicated a major part of his career to the development of methods in mass spectrometry for applications in clinics, from anatomical pathology to clinical pharmacology. Accordingly, he has set up new MS laboratories in different german academic medical and cancer research institutions (University Hospital Heidelberg, DKFZ). Since September 2024, Dr. Longuespée is actively involved in pharmaceutical research and the development of biologics in the Contract Research Organization NovAliX (France).